PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
30-Mar-2020 Imfinzi approved in the US for extensive-stage small cell lung cancer AstraZeneca
30-Mar-2020 Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic Abeona Therapeutics
30-Mar-2020 LATEST ACC DATA: Phase III Forxiga DAPA-HF Trial Sub-analysis shows consistent effect regardless of background therapy AstraZeneca
30-Mar-2020 Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 Sanofi
30-Mar-2020 Faron Pharmaceuticals Oy: Completion of Part 1 dose finding stage of the MATINS Phase I/II Study Faron Pharmaceuticals Ltd
30-Mar-2020 Ergomed’s PrimeVigilance Announces Provision of Clinical Safety Services for COVID-19 Clinical Trial Program Ergomed plc
30-Mar-2020 ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology ImaginAb Inc
30-Mar-2020 Envision Pharma Group ranked in Top 10 of the fastest-growing UK companies in pharma Envision Pharma Group
27-Mar-2020 Sanofi receives positive CHMP opinion for Sarclisa® (isatuximab) for the treatment of relapsed and refractory multiple myeloma Sanofi
27-Mar-2020 LifeArc launches £10 million research fund to address the challenges of COVID-19 LifeArc
27-Mar-2020 Board Changes NMC Health plc
27-Mar-2020 Babylon launches COVID-19 Care Assistant for the Coronavirus pandemic Babylon
26-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep
26-Mar-2020 ZAGENO Releases COVID-19 Data Addressing the Laboratory Supply Chain ZAGENO
26-Mar-2020 Berry Global Provides Protection Materials across Europe Berry Global Group, Inc.
26-Mar-2020 ISCT takes a stand against organizations marketing unproven COVID-19 cell and gene therapies The International Society for Cell & Gene Therapy (ISCT)
26-Mar-2020 Roche response to COVID-19 pandemic Roche
26-Mar-2020 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial Novavax, Inc.
26-Mar-2020 Emergent BioSolutions Signs Development and Manufacturing Agreement with Vaxart for their Experimental Oral Vaccine Candidate for Coronavirus Disease Emergent BioSolutions Inc
26-Mar-2020 Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant Ology Bioservices Inc